GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $4.71 $5.41 Friday, 19th Apr 2024 AUPH stock ended at $4.99. This is 3.74% more than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 4.92% from a day low at $4.78 to a day high of $5.01.
90 days $4.71 $8.49
52 weeks $4.71 $12.42

Historical Aurinia Pharmaceuticals Inc prices

Date Open High Low Close Volume
2020-10-26 $15.53 $15.89 $15.23 $15.42 595 064
2020-10-23 $15.31 $15.70 $15.05 $15.66 653 194
2020-10-22 $14.95 $15.39 $14.89 $15.19 352 325
2020-10-21 $15.31 $15.42 $14.90 $15.02 615 445
2020-10-20 $15.60 $15.75 $15.07 $15.31 661 102
2020-10-19 $15.63 $15.75 $15.50 $15.58 431 937
2020-10-16 $15.61 $15.81 $15.49 $15.49 355 639
2020-10-15 $15.44 $15.58 $15.14 $15.55 527 258
2020-10-14 $15.74 $15.77 $15.40 $15.58 485 293
2020-10-13 $15.65 $15.75 $15.42 $15.67 536 244
2020-10-12 $15.84 $15.86 $15.50 $15.70 556 447
2020-10-09 $15.71 $15.87 $15.47 $15.68 551 483
2020-10-08 $15.50 $15.70 $15.43 $15.50 757 781
2020-10-07 $15.78 $15.78 $15.15 $15.48 1 289 128
2020-10-06 $14.99 $15.97 $14.99 $15.22 1 847 038
2020-10-05 $14.16 $15.05 $14.11 $15.00 1 320 895
2020-10-02 $14.40 $14.58 $14.02 $14.04 984 298
2020-10-01 $14.79 $14.90 $14.46 $14.63 994 173
2020-09-30 $14.53 $14.89 $14.49 $14.73 871 774
2020-09-29 $14.36 $14.66 $14.30 $14.56 665 323
2020-09-28 $14.36 $14.52 $14.17 $14.36 571 377
2020-09-25 $14.01 $14.44 $13.97 $14.25 466 330
2020-09-24 $13.96 $14.11 $13.65 $14.04 903 231
2020-09-23 $14.86 $14.86 $14.07 $14.10 881 477
2020-09-22 $15.00 $15.01 $14.17 $14.82 1 046 739
Click to get the best stock tips daily for free!

About Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.... AUPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT